PROVIDER PROFILE · NPI 1396828588

Lucio Nobile

Medical OncologyFresno, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,379

Beneficiaries

—

Total drug cost

$5.2M

Distinct drugs

Brand share

25.2%

Top prescribed drugs

Dexamethasone111 claims

Lenalidomide106 claims

Abiraterone Acetate101 claims

Prednisone85 claims

Anastrozole71 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$27

Payment records

By payment type

Food and Beverage$27

REFERRAL NETWORK

Where Lucio Nobile's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 7 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NAYLOR, FREDRICK	57	174
Robert Havard Hematology-Oncology · Visalia, CA	44	281
Francis Mccully Diagnostic Radiology · Chester Springs, PA	17	29

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
KAWEAH DELTA HEALTH CARE DISTRICT	70	289
NAYLOR, FREDRICK	67	190
Shu Hsu Hematology-Oncology · Visalia, CA	52	311
Robert Havard Hematology-Oncology · Visalia, CA	50	385
Laboratory Corporation Of America Clinical Laboratory · San Diego, CA	16	31
Aaron Berkey Diagnostic Radiology · Visalia, CA	16	34
Bhupinder Chatrath Hematology-Oncology · Hanford, CA	15	43

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history